TAF11L14

Across TCGA pan-cancer cohorts, TAF11L14 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated TAF11L14 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher TAF11L14 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TAF11L14 expression acts as an unfavorable survival marker, although some lineages such as LIHC show a favorable association.

STAD, THCA, and CESC are the cancer types where TAF11L14 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.284	0.730	<.001	72	view →
THCA	DFS	Tertile	III,IV	0.495	0.900	<.001	48	view →
CESC	OS	Tertile	IV	0.091	0.593	<.001	36	view →
HNSC	DFS	Tertile	All	0.392	0.675	.010	36	view →
LUSC	OS	Tertile	II,III,IV	0.153	0.537	.022	27	view →
BLCA	DFS	Tertile	III,IV	0.163	0.493	.036	21	view →
GBM	OS	Tertile	All	0.005	0.416	<.001	18	view →
SKCM	OS	Tertile	IV	0.167	0.657	.003	18	view →
UCEC	DFS	Tertile	All	0.828	0.909	.009	18	view →
LIHC	DFS	Tertile	III,IV	0.631	0.235	.021	12	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →
LUAD	OS	Tertile	III,IV	0.228	0.677	.015	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

TAF11L14–STAD (DFS)

Open the STAD breakdown →